Ten Years of Euromelanoma in Hungary Nationwide Trends and Risk Factors for Skin Cancer in Central–Eastern Europe /

Background/Objectives: Large-scale, country-specific data on skin cancer predictors are scarce in Hungary. The Euromelanoma campaign offers a decade-long opportunity to investigate constitutional, behavioral, and motivational risk factors in a Central European setting through a national cross-sectio...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Papp Benjamin Tamás
Toplenszky Krisztina
Ócsai Henriette
Csányi Ildikó
Kemény Lajos
Gyulai Rolland Péter
Oláh Judit Magdolna
Baltás Eszter
Dokumentumtípus: Cikk
Megjelent: 2025
Sorozat:CANCERS 17 No. 23
Tárgyszavak:
doi:10.3390/cancers17233749

mtmt:36470999
Online Access:http://publicatio.bibl.u-szeged.hu/40174
LEADER 02911nab a2200301 i 4500
001 publ40174
005 20260522124152.0
008 260522s2025 hu o 000 eng d
022 |a 2072-6694 
024 7 |a 10.3390/cancers17233749  |2 doi 
024 7 |a 36470999  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a eng 
100 1 |a Papp Benjamin Tamás 
245 1 0 |a Ten Years of Euromelanoma in Hungary  |h [elektronikus dokumentum] :  |b Nationwide Trends and Risk Factors for Skin Cancer in Central–Eastern Europe /  |c  Papp Benjamin Tamás 
260 |c 2025 
300 |a 13 
490 0 |a CANCERS  |v 17 No. 23 
520 3 |a Background/Objectives: Large-scale, country-specific data on skin cancer predictors are scarce in Hungary. The Euromelanoma campaign offers a decade-long opportunity to investigate constitutional, behavioral, and motivational risk factors in a Central European setting through a national cross-sectional analysis. Methods: Between 2009 and 2018, Hungarian participants underwent dermatological screening. Diagnoses of clinically suspicious skin cancers were based on dermoscopic assessment, as histopathological confirmation was not systematically available. Among 18,598 standardized surveys, logistic regression identified independent predictors of clinically suspicious skin cancers overall and separately for melanoma and non-melanoma skin cancers (NMSCs). Results: Clinically suspicious skin cancers were detected in 3.9% of participants (1.7% melanoma, 2.3% NMSC). Strong predictors across all cancer types were atypical nevi (OR 4.75), personal history of NMSC (OR 3.42), and melanoma (OR 1.99). For melanoma, atypical nevi (OR 13.12), prior melanoma (OR 5.95), heavy sunbed use (OR 2.15), and trunk lentigines (OR 1.47) were significant. For NMSC, age (OR 1.08 per year), personal history of NMSC (OR 4.75), family history of melanoma (OR 2.41), and atypical nevi (OR 1.76) were dominant. Screening motivation influenced detection: participants attending for a changing lesion had higher odds of suspicious findings, whereas those attending for routine checks, family/friend history, or “many moles” had lower odds. Conclusions: Over a decade of Euromelanoma screening, atypical nevi, prior skin cancer history, and heavy sunbed use emerged as the strongest predictors of suspicious skin cancers. Participant motivation shaped detection patterns, supporting risk-stratified screening, targeted public education, and stricter regulation of artificial ultraviolet exposure. 
650 4 |a Klinikai orvostan 
700 0 1 |a Toplenszky Krisztina  |e aut 
700 0 1 |a Ócsai Henriette  |e aut 
700 0 1 |a Csányi Ildikó  |e aut 
700 0 1 |a Kemény Lajos  |e aut 
700 0 1 |a Gyulai Rolland Péter  |e aut 
700 0 1 |a Oláh Judit Magdolna  |e aut 
700 0 1 |a Baltás Eszter  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/40174/1/cancers-17-03749.pdf  |z Dokumentum-elérés